Europe Biopharmaceutical PEC Market to reach $25.02 billion by 2030

1. Europe Biopharmaceutical Processing Equipment and Consumables Market to be Worth $25.02 Billion by 2030

2. Europe biopharmaceutical processing equipment & consumbles Market to be worth $25.02 billion by 2030 Meticulous Research®– a leading global market research company, published a research report titled, “Europe Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User - Forecast to 2030.” According to this latest publication from Meticulous Research, the Europe biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 9.7% to reach $25.02 billion by 2030. The growth of this market is driven by factors such as the growth of the biopharmaceuticals market, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment. However, biopharmaceuticals' complex development and manufacturing process restrain the market’s growth. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/europe-biopharmaceutical-processing-equipment-and- consumables-market-5551 Furthermore, the shift towards Bioprocessing 4.0 and the rising adoption of personalized medicine are expected to offer significant market growth opportunities. The intensive capital requirements for biopharmaceutical production pose a major challenge to the market’s growth. The use of disposable processing equipment for commercial production and the rising focus on continuous bioprocessing are prevailing trends in the Europe biopharmaceutical processing equipment and consumables market. Europe Biopharmaceutical Processing Equipment and Consumables Market Market: Future Outlook The Europe Biopharmaceutical Processing Equipment and Consumables Market is segmented based on Product Type [Filtration Systems, Chromatography Equipment and Consumables (Consumables, Equipment), Bioreactors (Reusable Bioreactors, Disposable/Single-use Bioreactors), Cell Culture Products (Cell Culture Media {Cell Culture Media, by Physical Form [Dry Powder Media, Liquid Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Europe biopharmaceutical processing equipment & consumbles Market to be worth $25.02 billion by 2030 Media], Cell Culture Media, by Type [Off-the-Shelf Media, Custom Media], Cell Culture Media, by Source [Chemically Defined Media, Natural Media]}, Reagents and Supplements, Cell and Cell Lines, Serum), Mixing Systems, Bioprocessing Containers (BPC), Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Equipment and Consumables, Service], Application [Commercial Bioproduction, Vaccine Manufacturing, (Monoclonal Antibody Production, Recombinant Protein Production, Cell and Gene Therapy), Research Bioproduction], End User [Pharmaceutical and Biopharmaceutical Companies, Contract Development Manufacturing Organizations (CDMOs), Academia and Research Institutes]. Download Sample Report Here- https://www.meticulousresearch.com/download-sample- report/cp_id=5551 Among the product types, in 2023, the filtration systems segment is expected to account for the largest share of the Europe biopharmaceutical processing equipment and consumables market. The biopharmaceutical industry needs different filtration methods depending on what sort of solution is being used. Filtration is commonly employed in bioprocesses to remove undesirable particles like cell debris from cultures, viruses, and other bacteria. The largest share of this segment is attributed to the increasing demand for innovative filtration and separation techniques owing to the increasing production of biotherapeutic molecules. Among the applications, the commercial bioproduction segment is projected to grow at the highest CAGR over the forecast period. The large market share of this segment can be attributed to the growing consumption of biopharmaceutical equipment and consumables in commercial production and the growing demand for biopharmaceutical products. Among the end users, in 2023, the pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the Europe Biopharmaceutical Processing Equipment and Consumables market. The pharmaceutical and biopharmaceutical companies have witnessed significant growth in recent years. The large market share of this segment can be attributed to the increasing demand for biopharmaceutical products and the growing adoption of single-use products. Furthermore, government initiatives and capacity expansion by biopharmaceutical manufacturing companies contribute to this segment's largest share. Request for Sample:https://www.meticulousresearch.com/request-sample-report/cp_id=5551 Geographic Review This research report analyzes countries and provides a comprehensive analysis of European countries Germany, France, the U.K., Italy, Switzerland, Spain, Ireland, Denmark, Belgium, and the Rest of Europe. In 2023, Germany is expected to account for the largest share of the Europe biopharmaceutical processing equipment and consumables market. The increase in pharmaceutical export, government grants, and funding to biotech and biopharmaceutical companies drives the growth of this market. For instance, in 2020, BioNTech SE (Germany), a biotech company, received funding of USD 424 million (EUR 375 million) from the German Federal Ministry of Education and Research to support the development of mRNA-based COVID-19 vaccines. Key Players Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Europe biopharmaceutical processing equipment & consumbles Market to be worth $25.02 billion by 2030 The key players profiled in the Europe biopharmaceutical processing equipment and consumables market report are Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), Solaris Biotechnology Srl (Italy), Thermo Fisher Scientific Inc. (U.S.), 3M Company (U.S.), Bio- Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), and Danaher Corporation (U.S.). Quick Buy: https://www.meticulousresearch.com/Checkout/77176576 Key questions answered in the report- •Which are the high-growth market segments in terms of product type, application, end user, and countries? •What was the historical market for Europe biopharmaceutical processing equipment and consumables across the globe? •What are the market forecasts and estimates for the period 2023–2030? •What are the major drivers, restraints, challenges, opportunities, and trends in the Europe biopharmaceutical processing equipment and consumables market? •Who are the major players in the Europe biopharmaceutical processing equipment and consumables market? •What is the competitive landscape, and who are the market leaders in the Europe biopharmaceutical processing equipment and consumables market? •What are the recent developments in the Europe biopharmaceutical processing equipment and consumables market? •What are the different strategies adopted by the major players in the Europe biopharmaceutical processing equipment and consumables market? •What are the geographical trends and high-growth countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com